| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 672170 | 2-Thiophenecarboxaldehyde, 5-[5-[5-(hydroxymethyl)- 2-thienyl]-2-furanyl]- | 0.0260391472224207 | 0.20578032 |
| NSC 710552 | Null | 0.0260391472224207 | 0.24280223 |
| NSC 754664 | 3-amino-N-(5-chloro-2-methylphenyl)-5-oxo-5,6,7,8-tetrahydrothieno[2,3-b]quinoline-2-carboxamide | 0.0260391472224207 | -0.012255691 |
| NSC 762889 | 6-Chloro-5-[2-(piperazin-1-yl)ethyl]-1,3-dihydro-2H-indol-2-one | 0.0260391472224207 | 0.058618972 |
| NSC 102225 | Null | 0.0267520285931239 | 0.38760385 |
| NSC 105827 | SANGIVAMYCIN,-THIO | 0.0267520285931239 | 0.4253253 |
| NSC 130279 | 7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 3,4-dihydro-3-.beta.-D-ribofuranosyl- (9CI) | 0.0267520285931239 | 0.27504735 |
| NSC 132277 | Ethanesulfonic acid, compd. with 1,6-dihydro-6,6-dimethyl-1-[4-(4-phenylbutyl)phenyl]-1,3,5-triazine-2,4-diamine (1:1) | 0.0267520285931239 | 0.21737559 |
| NSC 13275 | Null | 0.0267520285931239 | 0.38589206 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0267520285931239 | 0.38287245 |